Tom Bures | Chief Financial Officer |
Steve Yoder | President and Chief Executive Officer |
Hitto Kaufmann | Chief Scientific Officer |
Shane Olwill | Chief Development Officer |
Roger Song | Jefferies |
Jonathan Miller | Evercore ISI |
Matt Phipps | William Blair |
Good morning, ladies and gentlemen, and welcome to the Pieris Pharmaceuticals Second Quarter Earnings Call. I will now turn the program over to Tom Bures, Chief Financial Officer.
Good morning, everyone, and thank you for joining us for our second quarter 2022 conference call and corporate update.
On the call today, we have Steve Yoder, our President and CEO, who will provide a corporate overview and outlook on our pipeline; Hitto Kaufmann, our Chief Scientific Officer; and Shane Olwill, our Chief Development Officer, who will be available for Q&A.
You can access the press release released this morning on the Investor Relations page of our website at www.pieris.com.